Fulgent Genetics, Inc.

FLGT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$7-$19-$12-$6
Dep. & Amort.$6$6$6$6
Deferred Tax-$1$0$0-$2
Stock-Based Comp.$10$10$11$10
Change in WC$2-$39-$10$16
Other Non-Cash$0$11$1$1
Operating Cash Flow$11-$30-$4$25
Investing Activities
PP&E Inv.-$6-$7-$5-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$19$0$0-$98
Inv. Sales/Matur.$40$60$32$75
Other Inv. Act.$4$0$0$0
Investing Cash Flow$19$53$28-$27
Financing Activities
Debt Repay.-$0-$0-$1-$0
Stock Issued$0$0$0$0
Stock Repurch.-$0-$3-$11-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$0-$3-$11-$0
Forex Effect$0$0$0-$0
Net Chg. in Cash$30$21$12-$3
Supplemental Information
Beg. Cash$88$67$55$58
End Cash$118$88$67$55
Free Cash Flow$5-$37-$9$21